Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (19)
Sowmya Swamy, Sahibzadi Mahrukh Noor & Roy O. Mathew. (2023) Cardiovascular Disease in Diabetes and Chronic Kidney Disease. Journal of Clinical Medicine 12:22, pages 6984.
Crossref
Crossref
Lina Badimon, Guiomar Mendieta & Gemma Vilahur. (2023) Statins revisited: therapeutic applications beyond lipid lowering?. European Heart Journal 44:25, pages 2332-2334.
Crossref
Crossref
Harold E Bays, Anandita Agarwala, Charles German, Priyanka Satish, Adedapo Iluyomade, Ramzi Dudum, Aarti Thakkar, Mahmoud Al Rifai, Anurag Mehta, Aneesha Thobani, Yousif Al-Saiegh, Adam J Nelson, Samip Sheth & Peter P. Toth. (2022) Ten things to know about ten cardiovascular disease risk factors – 2022. American Journal of Preventive Cardiology 10, pages 100342.
Crossref
Crossref
Ioannis Parthymos, Michael S Kostapanos, Dimitri P Mikhailidis & Matilda Florentin. (2022) Lipoprotein (a) as a treatment target for cardiovascular disease prevention and related therapeutic strategies: a critical overview. European Journal of Preventive Cardiology 29:5, pages 739-755.
Crossref
Crossref
Panisa Manasirisuk, Nanthaphan Chainirun, Somsak Tiamkao, Sunee Lertsinudom, Kutcharin Phunikhom & Kittisak Sawanyawisuth. (2022) Long Term Efficacy of Generic Atorvastatin by a University Hospital Database. Open Access Macedonian Journal of Medical Sciences 10:A, pages 947-950.
Crossref
Crossref
Xinliang Zou, Li Nie, Yi Liao, Zhihui Liu, Wanxiang Zheng, Xiaolong Qu, Xiang Xu, Haoran Qin, Haidong Wang, Jianping Liu, Guoxiang He & Tao Jing. (2022) Effects of statin therapy and treatment duration on cardiovascular disease risk in patients with nephrotic syndrome: A nested case–control study. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 42:4, pages 311-319.
Crossref
Crossref
Mukut Sharma, Vikas Singh, Ram Sharma, Arnav Koul, Ellen T. McCarthy, Virginia J. Savin, Trupti Joshi & Tarak Srivastava. (2022) Glomerular Biomechanical Stress and Lipid Mediators during Cellular Changes Leading to Chronic Kidney Disease. Biomedicines 10:2, pages 407.
Crossref
Crossref
Maciej Banach, Paweł Burchardt, Krzysztof Chlebus, Piotr Dobrowolski, Dariusz Dudek, Krzysztof Dyrbuś, Mariusz Gąsior, Piotr Jankowski, Jacek Jóźwiak, Longina Kłosiewicz-Latoszek, Irina Kowalska, Maciej Małecki, Aleksander Prejbisz, Michał Rakowski, Jacek Rysz, Bogdan Solnica, Dariusz Sitkiewicz, Grażyna Sygitowicz, Grażyna Sypniewska, Tomasz Tomasik, Adam Windak, Dorota Zozulińska-Ziółkiewicz & Barbara Cybulska. (2021) 2021 PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on the diagnosis and therapy of lipid disorders in Poland. Diagnostyka Laboratoryjna 57:1, pages 1-99.
Crossref
Crossref
Zlatko Fras & Dimitri P. Mikhailidis. (2021) Have We Learnt all from IMPROVE-IT? Part I. Core Results and Subanalyses on the Effects of Ezetimibe Added to Statin Therapy Related to Age, Gender and Selected Chronic Diseases (Kidney Disease, Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease). Current Vascular Pharmacology 19:5, pages 451-468.
Crossref
Crossref
Andrey V. Susekov, Ludmila A. Korol & Gerald F. Watts. (2021) Bempedoic Acid in the Treatment of Patients with Dyslipidemias and Statin Intolerance. Cardiovascular Drugs and Therapy 35:4, pages 841-852.
Crossref
Crossref
Tianfeng Wan & Zilin Chen. (2021) Covalent organic nanospheres modified magnetic nanoparticles for extraction of blood lipid regulators in water samples. Journal of Separation Science 44:11, pages 2301-2309.
Crossref
Crossref
Paul Valensi, Gaétan Prévost, Sara Pinto, Jean-Michel Halimi & Erwan Donal. (2021) The impact of diabetes on heart failure development: The cardio-renal-metabolic connection. Diabetes Research and Clinical Practice 175, pages 108831.
Crossref
Crossref
Harold E. Bays, Pam R. Taub, Elizabeth Epstein, Erin D. Michos, Richard A. Ferraro, Alison L. Bailey, Heval M. Kelli, Keith C. Ferdinand, Melvin R. Echols, Howard Weintraub, John Bostrom, Heather M. Johnson, Kara K. Hoppe, Michael D. Shapiro, Charles A. German, Salim S. Virani, Aliza Hussain, Christie M. Ballantyne, Ali M. Agha & Peter P. Toth. (2021) Ten things to know about ten cardiovascular disease risk factors. American Journal of Preventive Cardiology 5, pages 100149.
Crossref
Crossref
Alexandros G. Sachinidis, Dragana Nikolic, Anca Pantea Stoian, Peter P. Toth & Manfredi Rizzo. 2021. Therapeutic Lipidology. Therapeutic Lipidology
173
189
.
Robin H. Lo & Richard J. Glassock. 2021. ASPC Manual of Preventive Cardiology. ASPC Manual of Preventive Cardiology
611
651
.
Woong Chol Kang, Minsu Kim, Sang Min Park, Byeong-Keuk Kim, Byoung-Kwon Lee & Hyuck Moon Kwon. (2020) Preventive Effect of Pretreatment with Pitavastatin on Contrast-Induced Nephropathy in Patients with Renal Dysfunction Undergoing Coronary Procedure: PRINCIPLE-II Randomized Clinical Trial. Journal of Clinical Medicine 9:11, pages 3689.
Crossref
Crossref
Charalambos Vlachopoulos, Ioanna Dima, Dimitrios Soulis, Dimitrios Terentes-Printzios, Ioannis Skoumas, Konstantinos Aznaouridis, Eirini Solomou, Dimitrios Richter & Dimitrios Tousoulis. (2020) Eligibility for PCSK-9 inhibitors treatment in acute coronary syndrome, chronic coronary artery disease and outpatient dyslipidemic patients. Atherosclerosis 303, pages 29-35.
Crossref
Crossref
Niki Katsiki, Dimitri P. Mikhailidis, Gani Bajraktari, Andre R. Miserez, Arrigo F.G. Cicero, Eric Bruckert, Maria-Corina Serban, Erkin Mirrakhimov, Fahad Alnouri, Željko Reiner, György Paragh, Amirhossein Sahebkar, Maciej Banach, Fahad Alnouri, Fahma Amar, Atanas G. Atanasov, Gani Bajraktari, Maciej Banach, Marcin A. Bartlomiejczyk, Bojko Bjelakovic, Eric Bruckert, Agata Bielecka-Dabrowa, Alberto Cafferata, Richard Ceska, Arrigo F.G. Cicero, Xavier Collet, Olivier Descamps, Nair Devaki, Dragan Djuric, Ronen Durst, Marat V. Ezhov, Zlatko Fras, Dan Gaita, Stephan von Haehling, Adrian V. Hernandez, Steven R. Jones, Jacek Jozwiak, Nona Kakauridze, Niki Katsiki, Amit Khera, Karam Kostner, Raimondas Kubilius, Gustavs Latkovskis, G.B. John Mancini, A. David Marais, Seth S. Martin, Julio Acosta Martinez, Mohsen Mazidi, Dimitri P. Mikhailidis, Erkin Mirrakhimov, Andre R. Miserez, Olena Mitchenko, Patrick Moriarty, Seyed Mohammad Nabavi, Demosthenes B. Panagiotakos, György Paragh, Daniel Pella, Peter E. Penson, Zaneta Petrulioniene, Matteo Pirro, Arman Postadzhiyan, Raman Puri, Ashraf Reda, Željko Reiner, Jemaa Riadh, Dimitri Richter, Manfredi Rizzo, Massimiliano Ruscica, Amirhossein Sahebkar, Naveed Sattar, Maria-Corina Serban, Abdulla M.A. Shehab, Aleksandr B. Shek, Cesare R. Sirtori, Claudia Stefanutti, Tomasz Tomasik, Peter P. Toth, Margus Viigimaa, Dragos Vinereanu, Branislav Vohnout, Michal Vrablik, Nathan D. Wong, Hung-I Yeh, Jiang Zhisheng & Andreas Zirlik. (2020) Statin therapy in athletes and patients performing regular intense exercise – Position paper from the International Lipid Expert Panel (ILEP). Pharmacological Research 155, pages 104719.
Crossref
Crossref
Harold Edward Bays. (2020) Ten things to know about ten cardiovascular disease risk factors (“ASPC Top Ten – 2020”). American Journal of Preventive Cardiology 1, pages 100003.
Crossref
Crossref